{
  "meta": {
    "id": "test118",
    "title": "Primary Headache (Part 1)",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "Which of the following mutations is known to be present in most of the patients with familial hemiplegic migraine?",
      "options": [
        {
          "label": "A",
          "text": "The Cav2.1 (P/Q)\u2013type voltage-gated calcium channel CACNA1A gene",
          "correct": true
        },
        {
          "label": "B",
          "text": "The Na+-K+ATPase ATP1A2 gene designated FHM 2",
          "correct": false
        },
        {
          "label": "C",
          "text": "The neuronal voltage-gated sodium channel SCN1A",
          "correct": false
        },
        {
          "label": "D",
          "text": "The Na+-K+ATPase ATP1A2 gene designated FHM 3",
          "correct": false
        }
      ],
      "correct_answer": "A. The Cav2.1 (P/Q)\u2013type voltage-gated calcium channel CACNA1A gene",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>The Cav2.1 (P/Q)\u2013type voltage-gated calcium channel CACNA1A gene Migraine genes identified by studying families with familial hemiplegic migraine (FHM) reveal the involvement of ion channels , suggesting that alterations in membrane excitability can predispose to migraine.</p>\n<p><strong>Highyeild:</strong></p><p>Familial hemiplegic migraine (FHM) Involved channel Gene FHM1 Most common 50%cases Cav 2.1 (P/Q)\u2013type voltage-gated calcium channel CACNA1A gene FHM2 20%cases Na+-K+ATPase ATP1A2 gene FHM3 Neuronal voltage-gated sodium channel SCN1A gene</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option: B &C. FHM1 is more common than FHM2,3. Option: D. the Na+K+ATPase-ATP1A2 gene causes FHM2 not FHM3.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1136a999",
      "audio": ""
    },
    {
      "text": "Environmental and sensory stimuli in migraineurs can act as what factor for headache?",
      "options": [
        {
          "label": "A",
          "text": "Amplifying factor only",
          "correct": false
        },
        {
          "label": "B",
          "text": "Initiating factor only",
          "correct": false
        },
        {
          "label": "C",
          "text": "Amplifying or initiating factor",
          "correct": true
        },
        {
          "label": "D",
          "text": "Resolving factor",
          "correct": false
        }
      ],
      "correct_answer": "C. Amplifying or initiating factor",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Amplifying or initiating factor Environmental and sensory stimuli in migraineurs can act as both initiating factors and amplifying factors for headaches.</p>\n<p><strong>Highyeild:</strong></p><p>Migraineurs Sensitive to environmental and sensory stimuli Migraine-prone patients do not habituate easily to sensory stimuli. This sensitivity is amplified in women during the menstrual cycle. Headache can be initiated or amplified by various triggers Glare Bright lights Sounds Hunger let-down from stress Physical exertion Stormy weather Barometric pressure changes Hormonal fluctuations during menses L ack of or excess sleep alcohol nitrates. Knowledge of a patient\u2019s susceptibility to specific triggers can be useful in management strategies involving lifestyle adjustments , although it is becoming recognized that some apparent triggers may in fact be part of the initial phase of the attack ; i.e., the premonitory phase or prodrome.</p>\n<p><strong>Random:</strong></p><p>Explanation For All Options:- Option: A , B. Option C is better. Option: D. Amplifies NOT Resolves.</p>\n<p><strong>Extraedge:</strong></p><p>Pathophysiology of Migraine :</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d7e4920e",
      "audio": ""
    },
    {
      "text": "Which of the following is the most common headache-related, and indeed neurologic, cause of disability in the world?",
      "options": [
        {
          "label": "A",
          "text": "Tension-type headache",
          "correct": false
        },
        {
          "label": "B",
          "text": "Migraine",
          "correct": true
        },
        {
          "label": "C",
          "text": "Stroke",
          "correct": false
        },
        {
          "label": "D",
          "text": "Cluster headache",
          "correct": false
        }
      ],
      "correct_answer": "B. Migraine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Migraine Migraine, the second most common cause of headache , and the most common headache-related , and indeed neurologic , cause of disability in the world, afflicts ~15 percent of women and 6 percent of men over a 1-year period.</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option: A.Tension-type headache - is reported to be the most common primary headache syndrome. Option: C. Stroke - is the second leading cause of death worldwide. Option: D. Cluster headache - is a relatively rare form of primary headache , although Nonetheless a common condition, with a population frequency of ~0.1 percent.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "485f9c1a",
      "audio": ""
    },
    {
      "text": "The most frequent symptom of migraine is?",
      "options": [
        {
          "label": "A",
          "text": "Photophobia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Visual disturbance",
          "correct": false
        },
        {
          "label": "C",
          "text": "Nausea",
          "correct": true
        },
        {
          "label": "D",
          "text": "Photopsia",
          "correct": false
        }
      ],
      "correct_answer": "C. Nausea",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Nausea Most frequent symptom of Migraine is nausea with 87 percent frequency.</p>\n<p><strong>Highyeild:</strong></p><p>SYMPTOM PATIENTS AFFECTED, % Nausea 87 Photophobia 82 Lightheadedness 72 Scalp tenderness 65 Vomiting 56 Visual disturbances 36 Paresthesias 33 Vertigo 33 Photopsia 26 Alteration of consciousness 18 Diarrhea 16 Fortification spectra 10 Syncope 10 Seizure 4 Confusional state 4</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option: A. Photophobia- 82 percent. Option: B. Visual disturbance- 36 percent . Option: D. Photopsia- 26 percent .</p>\n<p><strong>Extraedge:</strong></p><p>Strongest predictor of migraine diagnosis PIN the diagnosis P -Photophobia I -Impairment/disability N -Nausea Any 2 + \u2192 93% PPV 3/3 + \u2192 98% PPV</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8f1777d9",
      "audio": ""
    },
    {
      "text": "A 25-year-old patient presented with a complaint of severe unilateral headache associated with nausea and weakness of the right half of the body. He has a family history of the same. Further investigations and detailed examination revealed the patient to be suffering from Familial hemiplegic migraine. According to the International headache society 2018 Familial hemiplegic migraine is classified under which of the following ?",
      "options": [
        {
          "label": "A",
          "text": "Migraine without aura",
          "correct": false
        },
        {
          "label": "B",
          "text": "Migraine with aura",
          "correct": true
        },
        {
          "label": "C",
          "text": "Probable migraine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Chronic migraine",
          "correct": false
        }
      ],
      "correct_answer": "B. Migraine with aura",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Migraine with aura Familial hemiplegic migraine is under Hemiplegic migraine which is under Migraine with aura.</p>\n<p><strong>Highyeild:</strong></p><p>Migraine Migraine without aura Migraine with aura Migraine with typical aura Typical aura with headache Typical aura without headache Migraine with brainstem aura Hemiplegic migraine Familial hemiplegic migraine (FHM) Familial hemiplegic migraine type 1 Familial hemiplegic migraine type 2 Familial hemiplegic migraine type 3 Familial hemiplegic migraine, other loci Sporadic hemiplegic migraine Retinal migraine Chronic migraine Complications of migraine Status migrainosus Persistent aura without infarction Migrainous infarction Migraine aura-triggered seizure Probable migraine Probable migraine without aura Probable migraine with aura Episodic syndromes that may be associated with migraine Recurrent gastrointestinal disturbance Cyclical vomiting syndrome Abdominal migraine Benign paroxysmal vertigo Benign paroxysmal torticollis</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option: A, C & D. Doesn\u2019t contain Familial hemiplegic migraine .</p>\n<p><strong>Extraedge:</strong></p><p>Familial hemiplegic migraine Hemiplegia with migraine Full recovery of focal neurological features within 24 hr Familial hemiplegic migraine (FHM) Involved channel Gene FHM1 Most common 50%cases Cav 2.1 (P/Q)\u2013type voltage-gated calcium channel CACNA1A gene FHM2 20%cases Na+-K+ATPase ATP1A2 gene FHM3 Neuronal voltage-gated sodium channel SCN1A gene</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f2fe0f42",
      "audio": ""
    },
    {
      "text": "Which of the following is NOT a component of three drug combinations approved for use by the FDA for the treatment of mild to moderate migraine?",
      "options": [
        {
          "label": "A",
          "text": "Acetaminophen",
          "correct": false
        },
        {
          "label": "B",
          "text": "Aspirin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Caffeine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Metoclopramide",
          "correct": true
        }
      ],
      "correct_answer": "D. Metoclopramide",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Metoclopramide The combination of acetaminophen (paracetamol), aspirin, and caffeine has been approved for use by the FDA for the treatment of mild to moderate migraine.</p>\n<p><strong>Highyeild:</strong></p><p>Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Significantly reduces Severity of a migraine attack Duration of a migraine attack Many undiagnosed migraineurs self-treat with non-prescription NSAIDs. Most effective when taken early in the migraine attack. Efficacy is less than optimal in moderate or severe migraine attacks. Combinations- Acetaminophen (paracetamol), aspirin, and caffeine Approved for use by the S. Food and Drug Administration (FDA) Treatment of mild to moderate migraine . A spirin and metoclopramide shown to be comparable to a single dose of oral sumatriptan. Side effects Dyspepsia Gastrointestinal irritation.</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option: A, B & C. are a component of three drug combinations approved for use by the FDA for the treatment of mild to moderate migraine.</p>\n<p><strong>Extraedge:</strong></p><p>Migraine attack Attack per month Headache duration Headache Treatment options Mild Less than 1 up to 8 hours Mild Simple analgesics/ NSAIDs or their combinations (\u00b1 antiemetic) Moderate One or more attacks lasts for 6\u201324 hours more intense Functionally impaired. NSAIDs combinations/ a triptan/ ergot alkaloids (+ antiemetic) Severe 2\u20133 or more attacks severe throbbing headache often accompanied by for vertigo, vomiting, and other symptoms 12\u201348 hours grossly incapacitated A Triptan /ergot alkaloids (+ antiemetic) + Prophylaxis- 1. Propranolol/other \u03b2 blockers 2. Amitriptyline/ other tricyclic antidepressants 3. Flunarizine/other Ca2+ channel blockers 4. Valproate/ topiramate</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0479d6b4",
      "audio": ""
    },
    {
      "text": "A 23-year-old patient presented with a complaint of severe throbbing. unilateral headache associated with nausea. what is the mechanism of drug used in acute treatment:",
      "options": [
        {
          "label": "A",
          "text": "Inhibition of 5-HT1A receptors",
          "correct": false
        },
        {
          "label": "B",
          "text": "Inhibition of 5-HT1B receptors",
          "correct": false
        },
        {
          "label": "C",
          "text": "Stimulation of 5-HT1A receptors",
          "correct": false
        },
        {
          "label": "D",
          "text": "Stimulation of 5-HT1B receptors",
          "correct": true
        }
      ],
      "correct_answer": "D. Stimulation of 5-HT1B receptors",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Stimulation of 5-HT1B receptors Patient has a unilateral, throbbing headache associated with nausea and is a case of migraine . Triptan causes Stimulation of 5-HT1B/1D receptors, which can stop an acute migraine attack.</p>\n<p><strong>Highyeild:</strong></p><p>Migraine Gender Female > male Site Unilateral Type Throbbing Duration One day Migraine associated features Nausea,vomiting Headache Phonophobia Osmophobia Movement\u2192 headache Disabling headache Aura\u2192 classical migraine (High risk of stroke) On examination Scalp tenderness Focal deficits (no neck stiffness) CGRP(Calcitonin Gene Related Peptide) Treatment NSAIDs Metoclopramide/ Prochlorperazine Triptans-5HT1B/1D agonist Ergot Caffeine STATUS MIGRANS (HEADACHE >72 hr) i. v. steroids Dopamine agonists v. ketorolac Hydration GEpants (Ubrogepant Rimegepant) Prophylaxis Beta-blockers (Propranolol,Timolol ) Valproate Topiramate Tricyclic antidepressants (Amitriptyline, Nortriptyline) Monoclonal antibodies [ Erenumab(s.c.) galcanezumab(s.c.) Eptinezumab(i.v.)] Botulinum toxin</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option: A, B & C are incorrect</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0b96c9e5",
      "audio": ""
    },
    {
      "text": "A 19-year female came to the emergency with a complaint of severe unilateral headache aggravated by movement. She also has nausea and phonophobia. By which route can you administer the drug for acute treatment of her headache?",
      "options": [
        {
          "label": "A",
          "text": "Nasal",
          "correct": false
        },
        {
          "label": "B",
          "text": "Parenteral",
          "correct": false
        },
        {
          "label": "C",
          "text": "Oral",
          "correct": false
        },
        {
          "label": "D",
          "text": "Any of the above",
          "correct": true
        }
      ],
      "correct_answer": "D. Any of the above",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Any of the above The cause is most probably Migraine type headache. (unilateral, throbbing type, associated with Nausea, photophobia, aggravated by movement). Acute treatment will be Sumatriptan. Which is available in Oral, Nasal, and Parenteral forms.</p>\n<p><strong>Highyeild:</strong></p><p>Triptans act as antimigraine agents by selectively binding to the serotonin receptors 5-HT1B and 5-HT1D. Triptan binding to the vascular 5-HT1B receptors leads to vasoconstriction of the cranial arteries, which painfully dilate during a migraine attack. Contraindications Coronary artery disease. 5-HT 1B/1D Receptor Agonists\u2014Triptans Oral Ergotamine 1 mg, caffeine 100 mg Naratriptan Rizatriptan Sumatriptan Frovatriptan Almotriptan Eletriptan Zolmitriptan Nasal Dihydroergotamine Sumatriptan Zolmitriptan Parenteral Dihydroergotamine Sumatriptan</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option: A. Nasal-eg. Nasal spray of sumatriptan,zolmitriptan Option: B. Parenteral-eg. Injection Sumatriptan Option: C. Oral-eg. Oral sumatriptan,Naratriptan etc.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1ca25bca",
      "audio": ""
    },
    {
      "text": "Which of the following neuromodulation techniques is FDA approved for the treatment of migraine?",
      "options": [
        {
          "label": "A",
          "text": "Single-pulse transcranial magnetic stimulation (TMS)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Non-invasive vagus nerve stimulator (nVNS)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Both a and b",
          "correct": true
        },
        {
          "label": "D",
          "text": "Used but not approved by FDA yet",
          "correct": false
        }
      ],
      "correct_answer": "C. Both a and b",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Both a and b Single-pulse transcranial magnetic stimulation (TMS) and a non-invasive vagus nerve stimulator (nVNS) are FDA-approved for the treatment of Migrane.</p>\n<p><strong>Highyeild:</strong></p><p>FDA-approved nonpharmaceutical neuromodulation migraine treatment- Single-pulse transcranial magnetic stimulation (TMS) for the acute treatment of migraine. Two pulses can be applied at the onset of an attack, and this can be repeated. Safe where there is no cranial metal implant A noninvasive vagus nerve stimulator (nVNS) treatment of migraine attacks in adults. One to two 120-s doses may be applied for attack treatment Remote electrical neuromodulation Using a smartphone app Stimulates the upper arm for 30\u201345 min Transcutaneous supraorbital nerve stimulation for 60 min.</p>\n<p><strong>Random:</strong></p><p>Explanation For All Options:- Option A, B & C is better. Option D. These neuromodulation techniques are FDA approved.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f04b60d8",
      "audio": ""
    },
    {
      "text": "Which of the following is the treatment of choice which can completely suppress paroxysmal hemicrania?",
      "options": [
        {
          "label": "A",
          "text": "Topiramate",
          "correct": false
        },
        {
          "label": "B",
          "text": "Verapamil",
          "correct": false
        },
        {
          "label": "C",
          "text": "Piroxicam",
          "correct": false
        },
        {
          "label": "D",
          "text": "Indomethacin",
          "correct": true
        }
      ],
      "correct_answer": "D. Indomethacin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Indomethacin Indomethacin (25-75 mg tid) , can completely suppress attacks of paroxysmal hemicrania and is the treatment of choice for prevention of Paroxysmal hemicrania attack . Although therapy may be complicated by Indomethacin-induced gastrointestinal side effects , currently there are no consistently effective alternatives.</p>\n<p><strong>Highyeild:</strong></p><p>Trigeminal Autonomic Cephalalgias Cluster Paroxysmal hemicrania SUNCT SUNCT (Short lasting unilateral neuralgiform conjunctival tearing) Gender Male>Female Male=Female Male=Female Attack frequency 1/day to 8/day 1-20/day (more than 5/day) 3-200/day Attack duration 15 min-3hr (1hr) 2-30 min (15min) 5-240 sec (seconds) Cutaneous trigger No No YES Alcohol trigger YES No YES Migrainous YES YES YES Autonomic YES YES YES Reacts to Indomethacin No YES No Abortive Treatment Injection Triptans(DOC) O2 Not available Lidocaine preventive Verapamil Galcanezumab Indomethacin Lamotrigine (DOC) Topiramate Gabapentin</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option: A.Topiramate is helpful in some cases. Option: B.Verapamil , an effective treatment for cluster headaches, does not appear to be useful for paroxysmal hemicrania. Option: C. Piroxicam has been used, although it is not as effective as Indomethacin.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0b23bafe",
      "audio": ""
    },
    {
      "text": "All of the following are Characteristics that lead to a suspected diagnosis of SUNCT except?",
      "options": [
        {
          "label": "A",
          "text": "Cutaneous (or other) triggers of attacks",
          "correct": false
        },
        {
          "label": "B",
          "text": "Refractory period to triggering between attacks",
          "correct": true
        },
        {
          "label": "C",
          "text": "The lack of a response to indomethacin",
          "correct": false
        },
        {
          "label": "D",
          "text": "Apart from trigeminal sensory disturbance, normal neurologic examination",
          "correct": false
        }
      ],
      "correct_answer": "B. Refractory period to triggering between attacks",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Refractory period to triggering between attacks A lack of refractory period to trigger between attacks are characteristics that lead to a suspected diagnosis of SUNCT (Short lasting unilateral neuralgiform conjunctival tearing).</p>\n<p><strong>Highyeild:</strong></p><p>Characteristics that lead to a suspected diagnosis of SUNCT (Short lasting unilateral neuralgiform conjunctival tearing) are the cutaneous (or other) triggers of attacks a lack of refractory period to triggering between attacks the lack of a response to indomethacin .</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option: A & C. are characteristics of SUNCT (Short lasting unilateral neuralgiform conjunctival tearing) Option: D . Apart from trigeminal sensory disturbance , the neurologic examination is normal in primary SUNCT (Short lasting unilateral neuralgiform conjunctival tearing).</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3710e03a",
      "audio": ""
    },
    {
      "text": "A 25-year-old female has severe excruciating burning retro-orbital pain, it lasts for around 30 seconds and she gets 50 attacks per day. Which of the following is the most effective treatment for the prevention of her condition ?",
      "options": [
        {
          "label": "A",
          "text": "Topiramate",
          "correct": false
        },
        {
          "label": "B",
          "text": "Gabapentin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Carbamazepine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Lamotrigine",
          "correct": true
        }
      ],
      "correct_answer": "D. Lamotrigine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Lamotrigine This is a case of SUNCT (Short lasting unilateral neuralgiform conjunctival tearing) as the patient has burning retro-orbital pain(trigeminal Autonomic cephalgia) with each attack lasting only 30 sec and 50 attacks per day. The most effective treatment/Drug of choice for the prevention of SUNCT is Lamotrigine.</p>\n<p><strong>Highyeild:</strong></p><p>Trigeminal Autonomic Cephalalgias Cluster Paroxysmal hemicrania SUNCT SUNCT (Short lasting unilateral neuralgiform conjunctival tearing) Gender Male>Female Male=Female Male=Female Attack frequency 1/day to 8/day 1-20/day (more than 5/day) 3-200/day Attack duration 15 min-3hr (1hr) 2-30 min (15min) 5-240 sec (seconds) Cutaneous trigger No No YES Alcohol trigger YES No YES Migranious YES YES YES Autonomic YES YES YES Reacts to Indomethacin No YES No Abortive Treatment Injection Triptans(DOC) O2 Not available Lidocaine preventive Verapamil Galcanezumab Indomethacin (DOC) Lamotrigine (DOC) Topiramate Gabapentin</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option: A & B.Topiramate and gabapentin- may also be effective.But, not the Drug of choice for the prevention of SUNCT (Short lasting unilateral neuralgiform conjunctival tearing). Option: C. Carbamazepine- has been reported by patients to offer modest But, not the Drug of choice for the prevention of SUNCT (Short lasting unilateral neuralgiform conjunctival tearing).</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7d04376b",
      "audio": ""
    },
    {
      "text": "Which of the following statements about hemicrania continua is FALSE?",
      "options": [
        {
          "label": "A",
          "text": "Moderate and continuous unilateral pain",
          "correct": false
        },
        {
          "label": "B",
          "text": "The cause is unknown",
          "correct": false
        },
        {
          "label": "C",
          "text": "Failure to resolve pain with indomethacin",
          "correct": true
        },
        {
          "label": "D",
          "text": "Women are affected twice as often as men",
          "correct": false
        }
      ],
      "correct_answer": "C. Failure to resolve pain with indomethacin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Failure to resolve pain with indomethacin Hemicrania continua pain resolves completely with Indomethacin.</p>\n<p><strong>Highyeild:</strong></p><p>Hemicrania cont\u00ednua Age of onset ranges from 10 to 70 years Women are affected twice as often as Features- Moderate and continuous pain Unilateral Fluctuations of severe pain Complete resolution of pain with indomethacin Exacerbations that may be associated with autonomic features Conjunctival injection Lacrimation photophobia on the affected side. The cause is unknown. Treatment- Indomethacin other NSAIDs- No benefit The IM injection of 100 mg of indomethacin vs placebo injection- Diagnostic tool Topiramate nVNS(NonInvasive Vagal nerve stimulation) Occipital nerve stimulation( Patients who are intolerable to Indomethacin )</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option: A, B & D are true about Hemicrania Continua.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "53a126af",
      "audio": ""
    },
    {
      "text": "The below condition is related to which of the following drugs (on repeated doses) is used in the treatment of Migraine?",
      "options": [
        {
          "label": "A",
          "text": "NSAIDs",
          "correct": false
        },
        {
          "label": "B",
          "text": "Beta blockers",
          "correct": false
        },
        {
          "label": "C",
          "text": "Ergotamine",
          "correct": true
        },
        {
          "label": "D",
          "text": "Dopamine antagonists",
          "correct": false
        }
      ],
      "correct_answer": "C. Ergotamine",
      "question_images": [
        "https://dbmi-data.s3.ap-south-1.amazonaws.com/photos-1683855115446-QTDM125020IMG1.JPG"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Ergotamine The above condition is gangrene due to ergot use. The patient had taken repeated doses of ergotamine tartrate for Migraines. Ergotamine and Dihydroergotamine are used for the treatment of acute attacks of Migraines and act as nonselective 5HT1 agonists which decrease cerebral vasodilation and P a in They can also cause Vasospasms in limbs leading to gangrene.</p>\n<p><strong>Highyeild:</strong></p><p>Ergot alkaloids Ergotamine, methysergide, bromocriptine, pergolide A nonselective stimulation of 5-HT1 receptors Inhibition of \u03b1-adrenergic receptors Stimulation of dopamine receptors Dose A nonnauseating dose of ergotamine should be sought Because a dose that provokes nausea is too high and may intensify head pain. Oral (excluding sublingual) formulations of ergotamine also contains 100 mg caffeine (theoretically to enhance ergotamine absorption and possibly to add additional analgesic activity ). The average oral ergotamine dose for a migraine attack is 2 mg. Comparison with triptans A much higher incidence of nausea on ergot use than with triptans but less headache recurrence. Side effects Physiologic stimulation Formication vasospasm of limb (isolated or generalized ) \u2192 gangrene Myocardial and cerebral ischemia to infarction . Hypotension Bradycardia Involuntary movements Treatment of side effects Severe vasospasm Nitroprusside or nitroglycerine Mild-to moderate limb ischemia Prazosin (an \u03b11 blocker) Captopril Nifedipine Cyproheptadine (a serotonin receptor antagonist) For hallucinations and movement disorders dopamine receptor antagonists (antipsychotics)</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option: A. NSAIDs- causes gastrointestinal side effects . Option: B. Beta blockers -is are used in the prevention of migraine not treatment. Option: D. Dopamine antagonists -is are used in the treatment of vomiting in migraine and do not cause gangrene.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3d42cb31",
      "audio": ""
    },
    {
      "text": "Which of the following is false with regard to basilar migraine?",
      "options": [
        {
          "label": "A",
          "text": "It often occurs in children",
          "correct": false
        },
        {
          "label": "B",
          "text": "characterized by a typical migrainous aura associated with numbness",
          "correct": false
        },
        {
          "label": "C",
          "text": "Tingling sensation is not associated",
          "correct": true
        },
        {
          "label": "D",
          "text": "Ataxia of gait with occasional impairment of consciousness",
          "correct": false
        }
      ],
      "correct_answer": "C. Tingling sensation is not associated",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Tingling sensation is not associated Basilar migraine is characterized by numbness/ tingling in lips and extremities(Bilateral).</p>\n<p><strong>Highyeild:</strong></p><p>Migraine Characterized by Focal migraine Symptoms of migraine + Transient dysphagia Hemisensory symptoms Focal weakness Migraine sine Episodic visual disturbance without headache Elderly patients with a history of classical migraine are typically affected Retinal migraine Acute transient unilateral loss of vision Middle aged person without a history of migraine Ophthalmoplegic migraine Recurrent transient 3rd nerve palsy which begins after headache Familial hemiplegic migraine Hemiplegia with migraine Full recovery of focal neurological features within 24 hr Basilar migraine Occurs in children Typical migrainous aura associated with numbness tingling of lips and extremities(Bilateral) Ataxia of gait and speech Occasional impairment of consciousness.</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Options: A, B & D. are true about Basilar migraine.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3dbe0a3b",
      "audio": ""
    },
    {
      "text": "Which of the following is false about the simplified diagnostic criteria for Migraine?",
      "options": [
        {
          "label": "A",
          "text": "Repeated attack of 4 to 72 hrs with normal neurological examination and no other reasonable causes for headache",
          "correct": false
        },
        {
          "label": "B",
          "text": "At Least 2 of the following Headaches (a)Unilateral (b)Throbbing (c)Moderate to severe (d)Aggravated by exertion or routine physical activity (e)Headache 4hr-3 days",
          "correct": false
        },
        {
          "label": "C",
          "text": "At Least 1 of the following of (a) nausea and vomiting (b) photophobia and phonophobia",
          "correct": false
        },
        {
          "label": "D",
          "text": "None of the above",
          "correct": true
        }
      ],
      "correct_answer": "D. None of the above",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>None of the above None of the above statements are false about the simplified diagnostic criteria for migraines .</p>\n<p><strong>Highyeild:</strong></p><p>Simplified Diagnostic Criteria of Migraine A. Any 2 out of 5 should be present 1.     Headache 4hr-3 days 2.     Unilateral 3.     Throbbing 4.     Moderate to severe 5.     Aggravated by exertion or routine physical activity B. C. At least 1 out of 2 should be present 1.     Nausea/vomiting 2.     Photophobia+phonophobia D. At least 5 attacks E. No organic disease</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option: A, B & C. - are true about the simplified diagnostic criteria for Migraine .</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "927f7cd3",
      "audio": ""
    },
    {
      "text": "Which of the following is not true with regard to _gepants?",
      "options": [
        {
          "label": "A",
          "text": "It is used for acute treatment and prevention of Migraine",
          "correct": false
        },
        {
          "label": "B",
          "text": "It acts as a CGRP antagonist and blocks this peptide",
          "correct": false
        },
        {
          "label": "C",
          "text": "Acts by promoting vasoconstriction effect inhibiting of vasodilation Action of CGRP receptor",
          "correct": false
        },
        {
          "label": "D",
          "text": "Acts on nitrergic neurons which are 2nd order CGRP Neurons",
          "correct": true
        }
      ],
      "correct_answer": "D. Acts on nitrergic neurons which are 2nd order CGRP Neurons",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Acts on nitrergic neurons which are 2nd order CGRP Neurons Nitrergic neurons are first-order neurons releasing CGRP.</p>\n<p><strong>Highyeild:</strong></p><p>Oral depants: small-molecule CGRP receptor antagonists Mechanism of action: The calcitonin gene-related peptide ( CGRP ) is a strong vasodilator primarily found in nervous tissue. Nitrergic neurons are 1st order releasing CGRP Vasodilation in the Brain is involved in the development of Migraine and CGRP levels are increased during the Migraine attacks. Gepants act as a CGRP antagonist and block this peptide This constricts dilated blood vessels within the brain. And counters the vasodilation which is the cause of pain in Migraines. Indication: Acute treatment of migraine. FDA approved: Rimegepant-Both acute and preventive treatment Ubrogepant -Acute treatment Advantage: pain-free and most bothersome symptoms free at 2 hours The most bothersome symptom is derived by asking patients to identify which symptom-of nausea, photophobia, and phonophobia was most bothersome during the treated attack Well tolerated Side effects: mild nausea.</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option: A, B & C are correct.</p>\n<p><strong>Extraedge:</strong></p><p>Monoclonal antibodies against CGRP approved for migraine prophylaxis: Erenumab(s.c.) galcanezumab(s.c.) Eptinezumab(i.v</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "eaf47be1",
      "audio": ""
    },
    {
      "text": "Triptans act by which of the following mechanisms:",
      "options": [
        {
          "label": "A",
          "text": "Decreasing cerebral vasodilation",
          "correct": true
        },
        {
          "label": "B",
          "text": "Increasing cerebral vasoconstriction",
          "correct": false
        },
        {
          "label": "C",
          "text": "Does not affect cerebral vessels",
          "correct": false
        },
        {
          "label": "D",
          "text": "None of the above",
          "correct": false
        }
      ],
      "correct_answer": "A. Decreasing cerebral vasodilation",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Decreasing cerebral vasodilation Triptans act as antimigraine agents by selectively binding to the serotonin receptors 5-HT1B and 5-HT1D. Triptan binding to the vascular 5-HT1B receptors leads to vasoconstriction of the cranial arteries, which painfully dilate during a migraine attack.</p>\n<p><strong>Highyeild:</strong></p><p>Acute migraine treatment: NSAIDS- Ibuprofen Naproxen Triptans 5HT 1B/1D agonists Ergot Dihydroergotamine nasal spray Diclofenac Antiemetics Dopamine antagonists- Metoclopramide prochlorperazine</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Options: B, C & D. are incorrect statements.</p>\n<p><strong>Extraedge:</strong></p><p>table,tr,th,td {border:1px solid black;} 5-HT 1B/1D Receptor Agonists\u2014Triptans Oral Ergotamine 1 mg, caffeine 100 mg Naratriptan Rizatriptan Sumatriptan Frovatriptan Almotriptan Eletriptan Zolmitriptan Nasal Dihydroergotamine Sumatriptan Zolmitriptan Parenteral Dihydroergotamine Sumatriptan</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5382886f",
      "audio": ""
    },
    {
      "text": "Which of the following is not a criterion to define aura in Migraine?",
      "options": [
        {
          "label": "A",
          "text": "Gradual in onset",
          "correct": false
        },
        {
          "label": "B",
          "text": "Not fully reversible",
          "correct": true
        },
        {
          "label": "C",
          "text": "followed by headache within 60 minutes or headache preceding or simultaneously with aura",
          "correct": false
        },
        {
          "label": "D",
          "text": "lasting about 60 minutes",
          "correct": false
        }
      ],
      "correct_answer": "B. Not fully reversible",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Not fully reversible The aura in migraine is fully reversible.</p>\n<p><strong>Highyeild:</strong></p><p>Aura is defined by at least 3 of the following Fully reversible Lasting for 60 minutes Gradual onset Followed by a headache within 60 minutes or a headache preceding or simultaneously with aura. Migraine Aura + Classical migraine Increased risk of stroke Estrogen \u2192 OCPs (avoided) Aura - Without Aura Common migraine Aura: Typical -visual, sensory, dysphasic speech Hemiplegic migraine- one of the above +  motor weakness. table,tr,th,td {border:1px solid black;} Visual Aura Rating scale Visual symptom characteristic Risk score Duration 5-60 min 3 Develops gradually in more than or equal to 5 min 2 Scotoma 2 Zig-zag line(fortification) 2 Unilateral(homonymous) 1 Maximum VARS score 10 Migraine with aura diagnosis More or equal to 5</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option A, C & D. are useful criteria to diagnose Aura with migraine.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4f909639",
      "audio": ""
    },
    {
      "text": "Which of the following is not used in the treatment of moderate and severe Migraine?",
      "options": [
        {
          "label": "A",
          "text": "5HT1B /1D agonists",
          "correct": false
        },
        {
          "label": "B",
          "text": "NSAIDS",
          "correct": true
        },
        {
          "label": "C",
          "text": "Triptans",
          "correct": false
        },
        {
          "label": "D",
          "text": "Dopamine antagonist",
          "correct": false
        }
      ],
      "correct_answer": "B. NSAIDS",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>NSAIDS NSAIDS (Diclofenac and naproxen) are not effective in the treatment of Severe forms of migraine.</p>\n<p><strong>Highyeild:</strong></p><p>Migraine attack Attack per month Headache duration Headache Treatment options Mild Less than 1 Up to 8 hours Mild Simple analgesics/ NSAIDs or their combinations (\u00b1 antiemetic) Moderate One or more attacks lasts for 6\u201324 hours more intense Functionally impaired. NSAIDs combinations/ a triptan/ ergot alkaloids (+ antiemetic) Severe 2\u20133 or more attacks severe throbbing headache often accompanied by vertigo, vomiting and other symptoms 12\u201348 hours grossly incapacitated A Triptan /ergot alkaloids (+ antiemetic) + Prophylaxis- 1. Propranolol/other \u03b2 blockers 2. Amitriptyline/ other tricyclic antidepressants 3. Flunarizine/other Ca2+ channel blockers 4. Valproate/ topiramate</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option: A. 5HT1B /1D agonists and Triptans- are used in moderate and severe migraine treatment. Option: D. Dopamine antagonist used as antiemetic in mild/moderate/severe migraine.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6566bc47",
      "audio": ""
    },
    {
      "text": "A 23-year-old female presented with a pulsatile throbbing headache lasting 15 hrs associated with nausea and vomiting. Which of the following is known in the pathogenesis of her condition?",
      "options": [
        {
          "label": "A",
          "text": "vasoactive neuropeptides",
          "correct": false
        },
        {
          "label": "B",
          "text": "CGRP Calcitonin gene-related peptides",
          "correct": false
        },
        {
          "label": "C",
          "text": "cGMP",
          "correct": false
        },
        {
          "label": "D",
          "text": "Both a and b",
          "correct": true
        }
      ],
      "correct_answer": "D. Both a and b",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Both a and b Female patient with a pulsatile throbbing headache lasting almost the entire day , associated with nausea and vomiting is typical for Migraine headaches. Migraine is mainly known to be mediated by increasing levels of vasoactive peptides, mainly increasing CGRP which causes vasodilation effect and Pain.</p>\n<p><strong>Highyeild:</strong></p><p>Pathogenesis of migraine- The sensory sensitivity that is characteristic of migraine is probably due to dysfunction of monoaminergic sensory control systems located in the brainstem and hypothalamus. Activation of cells in the trigeminal nucleus \u2192 Release of vasoactive neuropeptides, particularly calcitonin gene-related peptide (CGRP), at vascular terminals of the trigeminal nerve and within the trigeminal nucleus. Centrally, the second-order trigeminal neurons cross the midline and project to the ventrobasal and posterior nuclei of the thalamus for further processing. Additionally, there are projections to the periaqueductal gray and hypothalamus , from which reciprocal descending systems have established antinociceptive effects. Other brainstem regions likely to be involved in descending modulation of trigeminal pain include the nucleus locus coeruleus in the pons and the rostral ventromedial medulla. Pharmacologic and other data point to the involvement of the neurotransmitter 5-hydroxytryptamine (5-HT; also known as serotonin) in migraine. There is dopamine receptor hypersensitivity in migraineurs, as demonstrated by the induction of yawning, nausea, vomiting, hypotension, and other symptoms of a migraine attack by dopaminergic agonists at doses that do not affect nonmigraineurs. Hypothalamic activation, anterior to that seen in cluster headache , has now been shown in the premonitory (prodromal) phase of migraine using functional imaging, and this may hold a key to understanding some part of the role of dopamine in the disorder. Migraine genes identified by studying families with familial hemiplegic migraine (FHM) reveal the involvement of ion channels, suggesting that alterations in membrane excitability can predispose to migraine. Functional neuroimaging has suggested that brainstem regions in migraine have specific involvement in Migraine.</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option: C. cGMP is a second messenger molecule that modulates various downstream effects, including vasodilation , retinal phototransduction, calcium homeostasis , and neurotransmission.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "17da42fa",
      "audio": ""
    },
    {
      "text": "A 23-year-old female presented with a pulsatile throbbing headache lasting 10 hrs associated with nausea and vomiting. Which of the following drugs will you use in prophylaxis of her condition?",
      "options": [
        {
          "label": "A",
          "text": "Propranolol",
          "correct": true
        },
        {
          "label": "B",
          "text": "Atenolol",
          "correct": false
        },
        {
          "label": "C",
          "text": "Carvedilol",
          "correct": false
        },
        {
          "label": "D",
          "text": "None of the above",
          "correct": false
        }
      ],
      "correct_answer": "A. Propranolol",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Propranolol</p>\n<p><strong>Highyeild:</strong></p><p>PREVENTIVE TREATMENTS FOR MIGRAINE Indications- Increasing frequency of migraine attacks with attacks that are either unresponsive or poorly responsive to abortive treatments four or more attacks a month. Commonly used Preventives- Beta-blockers Propranolol Metoprolol Timolol Anticonvulsants Valproate Topiramate Tricyclic antidepressants Amitriptyline Dosulepin Nortriptyline Venlafaxine Monoclonal antibodies against CGRP approved for migraine prophylaxis- Erenumab(s.c.) galcanezumab(s.c.) Eptinezumab(i.v.) Serotonin and tryptamine antagonist Pizotifen Neuromodulation Single-pulse transcranial magnetic stimulation (TMS) Onabotulinum toxin type A(Chronic migraine )</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option B. Atenolol & C. Carvedilol- are Beta-blockers but not approved for migraine prophylaxis.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "24e90640",
      "audio": ""
    },
    {
      "text": "A 35-year-old, male presented with frequent headaches on one side only. The pain is short-lived lasting 15 minutes and it is very severe. The pain is retroorbital and it is experienced all over the head. There are also complaints of tears coming from this patient's eye. All of the following are true regarding this condition except?",
      "options": [
        {
          "label": "A",
          "text": "Indomethacin is the treatment of choice",
          "correct": false
        },
        {
          "label": "B",
          "text": "Nasal congestion can be present",
          "correct": false
        },
        {
          "label": "C",
          "text": "Verapamil is the treatment of choice",
          "correct": true
        },
        {
          "label": "D",
          "text": "Lesion in sella turcica can be a reason for this condition",
          "correct": false
        }
      ],
      "correct_answer": "C. Verapamil is the treatment of choice",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Verapamil is the treatment of choice Patient has a unilateral , frequent headache associated with Retro Orbital pain and tears (Trigeminal Autonomic Cephalalgia) and each attack lasts 15 minutes . All these features point toward the diagnosis of Paroxysmal hemicrania. Verapamil is an effective treatment for cluster headaches. However, This is not useful in paroxysmal hemicrania.</p>\n<p><strong>Highyeild:</strong></p><p>Trigeminal Autonomic Cephalalgias Cluster Paroxysmal hemicrania SUNCT SUNCT (Short lasting unilateral neuralgiform conjunctival tearing) Gender Male>Female Male=Female Male=Female Attack frequency 1/day to 8/day 1-20/day (more than 5/day) 3-200/day Attack duration 15 min-3hr (1hr) 2-30 min (15min) 5-240 sec (seconds) Cutaneous trigger No No YES Alcohol trigger YES No YES Migranious YES YES YES Autonomic YES YES YES Reacts to Indomethacin No YES No Abortive Treatment Inj.Triptans(DOC) 100% O2 Not available Lidocaine preventive Verapamil Galcanezumab Indomethacin Lamotrigine Topiramate Gabapentin</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option: A. Indomethacin is the treatment of choice -In paroxysmal hemicrania, Indomethacin is the treatment of choice. This can completely suppress attacks of paroxysmal hemicrania Option: B . Nasal congestion can be present -Due to the involvement of autonomic phenomenon in paroxysmal hemicrania , features such as lacrimation, nasal congestion are seen in this patient Option: D. lesion in sella turcica can be a reason for this condition - Secondary paroxysmal hemicrania has been reported with lesions in the region of the sella turcica. Hence this option is true.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b9fd8a41",
      "audio": ""
    },
    {
      "text": "A patient was prescribed naproxen for acute migraine attacks. But symptoms did not improve. Hence sumatriptan was given to this patient. All of the following are true regarding this drug except?",
      "options": [
        {
          "label": "A",
          "text": "This drug can be given as iv preparation",
          "correct": false
        },
        {
          "label": "B",
          "text": "This drug can be given in a needle-free device",
          "correct": false
        },
        {
          "label": "C",
          "text": "This drug can be given in basilar migraine",
          "correct": true
        },
        {
          "label": "D",
          "text": "This can be given in case of failed NSAID therapy",
          "correct": false
        }
      ],
      "correct_answer": "C. This drug can be given in basilar migraine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>This drug can be given in basilar migraine Naproxen is a non-steroidal anti-inflammatory drug This is the initial treatment of an acute attack of Migraine. However in this patient NSAIDs treatment has failed Next sumatriptan was given This drug will cause vasoconstriction of blood vessels and this vasoconstriction of the basilar artery and its branches will worsen the cranial nerve deficits seen in these patients like diplopia, vertigo, and difficulty in swallowing. Therefore triptans are contra-indicated in basilar migraine.</p>\n<p><strong>Highyeild:</strong></p><p>Acute migraine treatment- NSAIDS- Ibuprofen Naproxen Triptans 5HT 1B/1D agonists Ergot Dihydroergotamine nasal spray Diclofenac Antiemetics Dopamine antagonists- Metoclopramide prochlorperazine</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option: A. This drug can be given as IV preparation - Sumatriptan administration by injection is approved by FDA . This can be given by IV dosing. Option: B . This drug can be given in a needle-free device - Sumatriptan, 4-6 mg sc , is effective in 50-80 percent of patients , and can now be administered by a needle-free device. Option: D .this can be given in case of failed NSAID therapy In the clinical situation of failed NSAIDs and analgesics , sumatriptan is in the first tier of treatment</p>\n<p><strong>Extraedge:</strong></p><p>TABLE 430-5 Clinical Stratification of Acute Specific Migraine CLINICAL SITUATION TREATMENT OPTIONS Failed NSAIDs/analgesics First-tier Sumatriptan 50 mg or 100 mg PO Almotriptan 12.5 mg PO Rizatriptan 10 mg PO Eletriptan 40 mg PO Zolmitriptan 2.5 mg PO Rimegepant 75 mg Ubrogepant 50 or 100 mg Lasmiditan 50, 100, or 200 mg Slower effect/better tolerability Naratriptan 2.5 mg PO Frovatriptan 2.5 mg PO Infrequent headache Ergotamine/caffeine 1-2/100 mg PO Dihydroergotamine nasal spray 2 mg Early nausea or difficulties taking tablets Zolmitriptan 5 mg nasal spray Sumatriptan 20 mg nasal spray Rizatriptan 10 mg MLT wafer Headache recurrence Ergotamine 2 mg (most effective PR/usually with caffeine) Naratriptan 2.5 mg PO Almotriptan 12.5 mg PO Eletriptan 40 mg Rimegepant 75 mg Ubrogepant 50 or 100 mg Tolerating acute treatments poorly Naratriptan 2.5 mg Almotriptan 12.5 mg Rimegepant 75 mg Ubrogepant 50, 100 mg Single-pulse transcranial magnetic stimulation Noninvasive vagus nerve stimulation Early vomiting Zolmitriptan 5 mg nasal spray Sumatriptan 25 mg PR Sumatriptan 6 mg SC Menses-related headache Prevention Ergotamine po at night Estrogen patches Rimegepant 75 mg po taken during the menses Treatment Triptans Dihydroergotamine nasal spray Very rapidly developing symptoms Zolmitriptan 5 mg nasal spray Sumatriptan 6 mg SC Dihydroergotamine 1 mg IM Abbreviation: NSAIDs, nonsteroidal anti-inflammatory drugs.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "792a17c9",
      "audio": ""
    },
    {
      "text": "In a patient, there are up to five attacks of migraine per month. Because of this, the doctor wanted to start prophylactic treatment on this patient. All of the following can be given in this patient except?",
      "options": [
        {
          "label": "A",
          "text": "Dosulepin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Propranolol",
          "correct": false
        },
        {
          "label": "C",
          "text": "Topiramate",
          "correct": false
        },
        {
          "label": "D",
          "text": "Ergotamine",
          "correct": true
        }
      ],
      "correct_answer": "D. Ergotamine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Ergotamine Patient has more than 4 attacks per month which is an indication to start Preventive therapy for Migraine. However, ergotamine is not used in preventive therapy because it can cause serious gangrene.</p>\n<p><strong>Highyeild:</strong></p><p>PREVENTIVE TREATMENTS FOR MIGRAINE Indications- Increasing frequency of migraine attacks with attacks that are either unresponsive or poorly responsive to abortive treatments four or more attacks a month. Commonly used Preventives- Beta-blockers Propranolol Metoprolol Timolol Anticonvulsants Valproate Topiramate Tricyclic antidepressants Amitriptyline Dosulepin Nortriptyline Venlafaxine Monoclonal antibodies against CGRP approved for migraine prophylaxis- Erenumab(s.c.) galcanezumab(s.c.) Eptinezumab(i.v.) Serotonin and tryptamine antagonist Pizotifen Neuromodulation Single-pulse transcranial magnetic stimulation (TMS) Onabotulinum toxin type A(Chronic migraine )</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Options A, B & C are used in Prophylaxis of Migraine.</p>\n<p><strong>Extraedge:</strong></p><p>Migraine attack Attack per month Headache duration Headache Treatment options Mild Less than 1 Up to 8 hours Mild Simple analgesics/ NSAIDs or their combinations (\u00b1 antiemetic) Moderate One or more attacks lasts for 6\u201324 hours more intense Functionally impaired. NSAIDs combinations/ a triptan/ ergot alkaloids (+ antiemetic) Severe 2\u20133 or more attacks severe throbbing headache often accompanied by vertigo, vomiting and other symptoms 12\u201348 hours grossly incapacitated A Triptan /ergot alkaloids (+ antiemetic) + Prophylaxis- 1. Propranolol/other \u03b2 blockers 2. Amitriptyline/other tricyclic antidepressants 3. Flunarizine/other Ca2+ channel blockers 4. Valproate/topiramate</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "facdafba",
      "audio": ""
    },
    {
      "text": "A 37-year-old male, had a very severe attack of headaches continuously for 10 nights. He gave a history of similar attacks 2 months ago after which he was asymptomatic until 10 days ago. He wanted to move in order to relieve the pain. All of the following are true regarding this condition except?",
      "options": [
        {
          "label": "A",
          "text": "There may be lacrimation associated with this condition",
          "correct": false
        },
        {
          "label": "B",
          "text": "There is male predominance",
          "correct": false
        },
        {
          "label": "C",
          "text": "Oral sumatriptan is very effective in this condition",
          "correct": true
        },
        {
          "label": "D",
          "text": "Patients to respond very well to oxygen inhalation",
          "correct": false
        }
      ],
      "correct_answer": "C. Oral sumatriptan is very effective in this condition",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Oral sumatriptan is very effective in this condition The pain-free interval of the headache , the worst headache as described by the patient, the nocturnal attack, the patient being a male, and the patient wanting to move during the attack all point us toward the diagnosis of cluster headache. Oral sumatriptan is not effective for the prevention or for acute treatment of cluster headaches.</p>\n<p><strong>Highyeild:</strong></p><p>Acute cluster headache treatment- Oxygen inhalation 100% oxygen at 10\u201312 L/min for 15\u201320 min. It appears that high flow and high oxygen content are important. Sumatriptan 6 mg SC Rapid in onset shorten an attack to 10\u201315 min Nasal sprays Sumatriptan (20 mg) Zolmitriptan (5 mg) Noninvasive vagus nerve stimulation (nVNS) three 2-min stimulation cycles applied consecutively at the onset of headache on the side of pain; this may be repeated after 9 min.</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Options: A & D. are true statements about Cluster headaches. Option: B. As cluster headache is a Trigeminal Autonomic Cephalalgia it may have Unilateral Red eye, Lacrimation, Rhinorrhoea, and Nasal congestion.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "96ba8ad3",
      "audio": ""
    },
    {
      "text": "Mrs. George, 24/female, presents to medicine OPD with h/o recurrent episodes of unilateral, throbbing headache since the past few months and occurring at a frequency of >1/week. Episodes are associated with nausea, vomiting, and photophobia and last for about a day and sometimes even 2 days. When these episodes occur, the patient is grossly incapacitated. The most likely diagnosis is",
      "options": [
        {
          "label": "A",
          "text": "Mild Migraine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Moderate Migraine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Severe Migraine",
          "correct": true
        },
        {
          "label": "D",
          "text": "ICSOL",
          "correct": false
        }
      ],
      "correct_answer": "C. Severe Migraine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Severe Migraine Patient has Unilateral, recurrent throbbing headache associated with nausea, vomiting, and photophobia . Point towards a diagnosis of Migraine headache. Migraine is the most common cause of disabling headaches. As the frequency of headache is more than 3 attacks/month and grossly incapacitate the patient it\u2019s a severe form of Migrane.</p>\n<p><strong>Highyeild:</strong></p><p>Migraine attack Attack per month Headache duration Headache Treatment options Mild Less than 1 Up to 8 hours Mild Simple analgesics/ NSAIDs or their combinations (\u00b1 antiemetic) Moderate One or more attacks lasts for 6\u201324 hours more intense Functionally impaired. NSAIDs combinations/ a triptan/ ergot alkaloids (+ antiemetic) Severe 2\u20133 or more attacks severe throbbing headache often accompanied by vertigo, vomiting and other symptoms 12\u201348 hours grossly incapacitated A Triptan /ergot alkaloids (+ antiemetic) + Prophylaxis- \u25cf Propranolol/other \u03b2 blockers \u25cf Amitriptyline/ other tricyclic antidepressants \u25cf Flunarizine/other Ca2+ channel blockers \u25cf Valproate/ topiramate</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option: A & B. mild and moderate migraine will have fewer attacks and won\u2019t cause gross incapacitation. Option: D. Intracranial space occupying lesion will have signs of raised ICP and may have focal neurological signs.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "528b3593",
      "audio": ""
    },
    {
      "text": "Mrs. Chandra, 62/Female, presented to the Medicine OPD with h/o recurrent episodes of headache lasting for 15-20 minutes, bilateral, throbbing in nature, and moderate to severe intensity. She said headaches would occur within a few hours after she went to bed and would occur at a frequency of 2-3 times/night often disrupting her sleep. As a result, she would wake up late in the morning and would often fall asleep while doing her household chores. Medical history is significant for uncontrolled HTN and DM. BP now in OPD is 150/90mm Hg. The rest of the examination is normal. The patient denies nausea, vomiting, and photophobia during the episodes. The most likely diagnosis, in this case, is ?",
      "options": [
        {
          "label": "A",
          "text": "Cluster Headache",
          "correct": false
        },
        {
          "label": "B",
          "text": "Migraine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Chronic Fatigue Syndrome",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hypnic Headache",
          "correct": true
        }
      ],
      "correct_answer": "D. Hypnic Headache",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Hypnic Headache Points in favor of hypnic headache are Age >60 years , female patient , Headache occurring soon after she goes to bed , Bilateral, moderately severe, Lasts 15-20 min , with recurrence of 2-3 times/night, no nausea/vomiting/photophobia. Also the patient has hypertension which is a treatable cause of hypnic headache.</p>\n<p><strong>Highyeild:</strong></p><p>Hypnic Headache: Female >Male after age 60 years The headaches last from 15\u201330 min moderately severe and Bilateral (may be unilateral and can be throbbing) begins a few hours after sleep onset falling back to sleep only to be awakened by a further attack a few hours later up to three repetitions of this pattern occur through the night Daytime naps can also precipitate head pain Photophobia, phonophobia, and nausea are usually absent The major secondary consideration in this headache type Poorly controlled hypertension 24-h blood pressure monitoring is recommended to detect this treatable condition. Treatment A bedtime dose of lithium carbonate Verapamil Caffeine at bedtime Flunarizine Indomethacin</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option: A.Cluster headache - is unilateral , usually associated with other autonomic signs and symptoms and is stabbing in nature. Option: B. Migraine is a unilateral headache and will be associated with Nausea/vomiting/photophobia. Option: C. Chronic fatigue does not have the above said specific symptoms.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "580d5570",
      "audio": ""
    }
  ]
}